Review Article
Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types
Table 1
Mean IC50 values () for the PPARγ ligands.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mean IC50 values from replicate experiments with this panel of cells for each of
the three PPARγ ligands are shown above, expressed in . Cell lines are grouped according to
cancer type. IC50 values from each cell line were compared by single
factor ANOVA analysis, with all lines showing significant differences as
indicated: . |